Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tuck

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|November 12, 2019
External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data CommonsDavid Cheng, Jaime Ramos-Cejudo, David Tuck, et al.
Journal of Virology|November 6, 2009
Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitorsDerek Daigle, Cynthia Megyola, Ayman El-Guindy, et al.
Journal of Virology|March 18, 2011
Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycleDerek Daigle, Lyn Gradoville, David Tuck, et al.
Australian Journal of Psychology|July 16, 2025
Belonging in their words: exploring early childhood perspectives using the draw, write, tell methodKelly-Ann Allen, Emily Berger, Louise McLean, et al.
Molecular Oncology|June 18, 2013
Translating next generation sequencing to practice: opportunities and necessary stepsSitharthan Kamalakaran, Vinay Varadan, Angel Janevski, et al.
Molecular Cancer Research : MCR|May 10, 2011
NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53Kathleen A Wilson, Sierra A Colavito, Vincent Schulz, et al.
JCO Clinical Cancer Informatics|October 19, 2020
Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs SystemJennifer La, David Cheng, Mary T Brophy, et al.
Blood|October 18, 2002
Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell lineZheng Lian, Yuval Kluger, Dov S Greenbaum, et al.
Breast Cancer Research and Treatment|February 3, 2012
Favorable outcome associated with an IGF-1 ligand signature in breast cancerLina Mu, David Tuck, Dionyssios Katsaros, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 2008
Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- miceEmanuela M Bruscia, Ping-Xia Zhang, Elisa Ferreira, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|November 12, 2019
External validation of a prognostic model for mortality among patients with non-small-cell lung cancer using the Veterans Precision Oncology Data CommonsDavid Cheng, Jaime Ramos-Cejudo, David Tuck, et al.
Journal of Virology|November 6, 2009
Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitorsDerek Daigle, Cynthia Megyola, Ayman El-Guindy, et al.
Journal of Virology|March 18, 2011
Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycleDerek Daigle, Lyn Gradoville, David Tuck, et al.
Australian Journal of Psychology|July 16, 2025
Belonging in their words: exploring early childhood perspectives using the draw, write, tell methodKelly-Ann Allen, Emily Berger, Louise McLean, et al.
Molecular Oncology|June 18, 2013
Translating next generation sequencing to practice: opportunities and necessary stepsSitharthan Kamalakaran, Vinay Varadan, Angel Janevski, et al.
Molecular Cancer Research : MCR|May 10, 2011
NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53Kathleen A Wilson, Sierra A Colavito, Vincent Schulz, et al.
JCO Clinical Cancer Informatics|October 19, 2020
Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs SystemJennifer La, David Cheng, Mary T Brophy, et al.
Blood|October 18, 2002
Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell lineZheng Lian, Yuval Kluger, Dov S Greenbaum, et al.
Breast Cancer Research and Treatment|February 3, 2012
Favorable outcome associated with an IGF-1 ligand signature in breast cancerLina Mu, David Tuck, Dionyssios Katsaros, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 2008
Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- miceEmanuela M Bruscia, Ping-Xia Zhang, Elisa Ferreira, et al.
Pageof 5